Impact of intravesical Bacillus Calmette-Guérin and chemotherapy on the bladder microbiome in patients with non-muscle invasive bladder cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Christopher,James

第一单位： Loyola University Medical Center, Department of Urology, Maywood, IL, United States.

作者： Christopher,James ^[1] ; Kayeromi,Gomez ^[2] ; Shalin,Desai ^[1] ; Hiten D,Patel ^[1] ; Goran,Rac ^[3] ; Chirag P,Doshi ^[1] ; Ryan,Dornbier ^[1] ; Petar,Bajic ^[1] ; Thomas,Halverson ^[1] ; Gopal N,Gupta ^[4] ; Marcus L,Quek ^[5] ; Alex,Gorbonos ^[5] ; Robert,Flanigan ^[1] ; Alan J,Wolfe ^[1]

作者单位： Loyola University Medical Center, Department of Urology, Maywood, IL, United States. ^[1] Department of Hematology/Oncology, Loyola University Chicago, Stritch School of Medicine Maywood, IL, United States. ^[2] Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States. ^[3] Department of Urology, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, United States. ^[4] Loyola University Chicago, Department of Microbiology and Immunology, Maywood, IL, United States. ^[5]

关键词 Bacillus Calmette-Guérin (BCG)bladder cancer intravesical gemcitabine intravesical therapy microbiome

主题词人类(Humans);卡介苗(BCG Vaccine);膀胱(Urinary Bladder);佐剂, 免疫(Adjuvants, Immunologic);膀胱肿瘤(Urinary Bladder Neoplasms);肿瘤侵润(Neoplasm Invasiveness)

DOI 10.3389/fcimb.2023.1125809

PMID 37091677

发布时间 2024-05-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交